Tag: HRS 2022
HRS 2022: S-ICD can be considered as an alternative to transvenous...
The use of a subcutaneous-implantable defibrillator (S-ICD, Boston Scientific) reduced the rate of major, lead-related complications by as much as 92% when compared to...
HRS 2022: Registry data support role of cardioneural ablation to address...
Findings of the US multicentre cardioneural ablation (CNA) registry were presented during a late-breaking clinical trial session at the Heart Rhythm Society’s 2022 annual...
HRS 2022: Same day discharge “benefits AF ablation patients”
Results of a study presented at the Heart Rhythm Society’s 2022 annual meeting (HRS 2022, 29 April–1 May, San Francisco, USA) show that the...
HRS 2022: AI-based app used to detect left-ventricular dysfunction
Use of an artificial intelligence (AI)-based app using electrocardiogram (ECG) signals recorded with an Apple Watch is able to identify left-ventricular dysfunction, research presented...
HRS 2022: Trio of studies demonstrate positive outcomes of CSP for...
The Heart Rhythm Society (HRS) has announced the findings of three clinical trials demonstrating positive outcomes of conduction system pacing (CSP) for patients in...
HRS 2022: Aggressive blood pressure control reduces risk of left ventricular...
Results from a new clinical trial found aggressive blood pressure (BP) control reduced the risk of left-ventricular conduction disease. This study is the first...